Biobeat

Petah Tikva, Israel Founded: 2014 • Age: 12 yrs
Body vitals are monitored non-invasively through wearable devices.

About Biobeat

Biobeat is a Healthcare company based in Petah Tikva (Israel) founded in 2014 by Johanan May. It operates as a body vitals are monitored non-invasively through wearable devices. It operates in the Healthcare and Technology sectors. Biobeat has raised $51 million across 3 funding rounds from investors including European Union, Ally Bridge Group and Orbimed. Its website bio-beat.com draws about 10 thousand monthly visits. Biobeat offers products and services including Cuff-less Blood Pressure Patch, In-Hospital Monitoring System, and Hospital at Home Solution. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Monitoring Devices. Its competitors include Withings, Ultrahuman, Tyto Care, iHealth Labs and Oura and 4 more; 8 of its 9 listed competitors have raised funding.

Company details

Biobeat offers a non-invasive body vitals monitoring wearable solution. It uses reflective Pulse Oximetry technology with their algorithm to allow for constant measurements of related body vitals. Sensor delivers a range of body vitals measurement including consciousness, saturation, pulse, temperature and perspiration. The devices are connected to a mobile app or a central monitoring system where the users data is stored. Data is then compared against a persons normal levels to identify life-threatening situations. It also allows data sharing with doctors and caregivers. They have released their products for athletes and Hospitals. Founded by Arik Ben Ishai Director of startups in the Rocket and Space Department of the Ministry of Defense, Israel.

  • Headquarters Petah Tikva, Israel
  • Founders Johanan May
  • Sectors
    Healthcare
    Technology
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website bio-beat.com
  • Social LinkedIn YouTube
Key Metrics
  • Total Equity Funding
    $51M (USD)

    in 3 rounds

  • Latest Funding Round
    $50M (USD), Series B

    Dec 2025

  • Investors

Products & Services of Biobeat

Biobeat offers a comprehensive portfolio of products and services, including Cuff-less Blood Pressure Patch, In-Hospital Monitoring System, and Hospital at Home Solution.

Cuff-less Blood Pressure Patch
Monitoring Device

Wireless chest patch for continuous 24-hour blood pressure tracking and hypertension detection.

In-Hospital Monitoring System
Medical Platform

Integrated system for real-time vital signs monitoring in clinical settings.

Hospital at Home Solution
Remote Care Device

Wireless tools for home-based blood pressure and health monitoring services.

Apps and channels of Biobeat

its YouTube channel Biobeat Technologies has 151 subscribers and 15 videos.

Biobeat Technologies
YouTube 151 subscribers 15 videos Science & Technology
Open channel

Videos from Biobeat

The most watched videos on Biobeat's YouTube channel, Biobeat Technologies (151 subscribers). Click a video to play it here.

Biobeat Solutions - Ambulatory Blood Pressure Monitor
2.6K views
Biobeat & TGH - Hospital at Home
1.9K views
AI & Early Warning Score
1.1K views
BPM Chest Monitor
1.1K views

More on Biobeat Technologies.

Funding Insights of Biobeat

Biobeat has successfully raised a total of $51M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $50 million completed in December 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $51M
  • Total Rounds 3
  • Last Round Series B β€” $50M
  • First Round $1M

    (Jun 2016)

  • Investors Count 4

All 3 funding rounds of Biobeat with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2025$50MSeries B–Ally Bridge Group, Orbimed
–
Oct 2019$188,475Grant––
Jun 2016$1MAngel Round––
–
Valuation history

4 investors in total: 4 institutional.

Investors in Biobeat

Biobeat has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, Ally Bridge Group and Orbimed.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
-
–ally-bridge.com-
-
–orbimed.com-
-
–elevagemedical.com-
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for Biobeat

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Biobeat

21 people are tracked at Biobeat (7 in leadership, 14 in team).

NameRoleGroup
Johanan May
Co-FounderLeadership
Sharon Dayan
VP MarketingLeadership
Israel Sarussi
Founder & Chief ScientistLeadership
Matania Gur Arie
VP, R&DLeadership
Arik Ben Ishay
Founder & CEOLeadership
Jay Heimsoth
Director Of SalesLeadership
Lior Ben Shettrit
VP, Business Development & SalesLeadership
Lidor Amitay
Software EngineerTeam
Daniel Hay
Mobile Application DeveloperTeam
Tom Gelvan
Embedded Software EngineerTeam
Nataly Antal
Business Development RepresentativeTeam
elisha berl
QA EngineerTeam
Mor Zukin
Algorithm DeveloperTeam
Ron Teller
QA Team LeadTeam
Tom Levin
Algorithm DeveloperTeam
Mark Guindon
Sales ManagerTeam
Anna Danielle Sherman
Operation & Customer Success ManagerTeam
Or Cohen
Technical LeadTeam
Chen Nahoom
DevOps EngineerTeam
Or Erenfeld
QA EngineerTeam

1 more people are available in the full profile.

Premium access

Complete people profiles for Biobeat

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Biobeat

3 dated milestones of Biobeat across 11 years, from founding to its latest funding, stage changes and deals.

  1. Founded Biobeat is founded.
  2. Funding First funding round of $1.0M.
  3. Funding Latest funding round, Series B, of $50.0M.

Competitors of Biobeat

Biobeat has 9 listed competitors in our database, 8 of them funded. They include Withings, Ultrahuman, Tyto Care, iHealth Labs and Oura, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
withings.com2008Moulineaux, France$93.83M39
Connected devices for health, sleep, and activity monitoring are developed.
ultrahuman.com2019Bengaluru, India$54.92M261
Metabolic health is tracked via devices and fitness platforms.
tytocare.com2011Netanya, Israel$199.5M–
Medical consultations are facilitated via self-exams and remote diagnostic devices.
ihealthlabs.com2010Mountain View, United States$25M104
Personal healthcare devices for vital monitoring are designed and produced.
ouraring.com2013Oulu, Finland$1.32B–
Health-tracking smart rings and biosensors are developed for biometric monitoring.
edwards.com1958Irvine, United States–19,800
Medical devices for structural heart disease are developed and provided.
biointellisense.com2018Redwood, United States$82M26
Vital signs are monitored via a single-use patch and platform.
endotronix.com2007East Peoria, United States$154.77M104
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring.
athelas.com2014Mountain View, United States$135.83M213
Provider of smart solutions for monitoring heart rate, weight, and blood pressure
Premium access

Detailed competitors of Biobeat

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Biobeat

The website of Biobeat (bio-beat.com) receives about 10.3K visits a month.

  • Monthly visits
    10.3K

    ▲ 58.9% vs previous month

Similar websites

Websites whose visitors overlap most with Biobeat. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
medaval.ie
100%
–#420,995View details
hilo.com
86%
313.8K#157,740View details
medicaldevice-network.com
86%
–#456,669View details
mindtecstore.com
mindtecstore.com
69%
–#607,869–
healthrecoverysolutions.com
60%
23.7K#1,188,182View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 6 similar websites and full traffic analytics for Biobeat

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 6 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Clinical IT & Data Platforms

10 companies that operate in the same segment as Biobeat (Clinical IT & Data Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of fitness memberships encompassing group classes, gyms, and at-home workouts
2016Bengaluru, Karnataka, IndiaUSD 716.99 M–1,832
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M––
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M–1,746
Tech-enabled mental health solutions for employers are provided.
2016New York, New York, United StatesUSD 473.73 M–3,902
App-based health insurance is offered to individuals and businesses.
2016Paris, Ile de France, FranceUSD 863.12 M–1,606
Virtual care programs for managing chronic diseases are provided.
2011San Francisco, California, United StatesUSD 450.12 MUSD 260.21 M992
AI-driven EMR and practice management software is delivered for clinics.
2010Boca Raton, Florida, United StatesUSD 329.17 M–2,470
Cloud-based administrative tools for healthcare providers are offered.
1997Watertown, United StatesUSD 40 M––
Membership-based primary care platform is offered for employees and consumers.
2007San Francisco, California, United StatesUSD 402.56 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Biobeat

Premium access

Complete news archive for Biobeat

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Biobeat

Biobeat was founded in 2014 and raised its 1st funding round 2 years after it was founded.

Biobeat is headquartered in Petah Tikva, Israel. It is registered at Petah Tikva, Central District, Israel.

Biobeat is a funded company, having raised a total of $51M across 3 funding rounds to date. The company's 1st funding round was a Angel Round of $1M, raised on Jun 2016.

Biobeat offers a non-invasive body vitals monitoring wearable solution. It uses reflective Pulse Oximetry technology with their algorithm to allow for constant measurements of related body vitals. Sensor delivers a range of body vitals measurement including consciousness, saturation, pulse, temperature and perspiration. The devices are connected to a mobile app or a central monitoring system where the users data is stored. Data is then compared against a persons normal levels to identify life-threatening situations. It also allows data sharing with doctors and caregivers. They have released their products for athletes and Hospitals. Founded by Arik Ben Ishai Director of startups in the Rocket and Space Department of the Ministry of Defense, Israel.

Biobeat's top competitors include Withings, Ultrahuman and Oura.

Biobeat offers Cuff-less Blood Pressure Patch, In-Hospital Monitoring System, and Hospital at Home Solution.

Biobeat has 4 investors. Key investors include European Union, Ally Bridge Group, Orbimed, and Elevage Medical Technologies.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available